These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 37553468)
1. Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT. Sanz J; Labopin M; Pabst T; Versluis J; Van Gorkom G; Meijer E; Gedde-Dahl T; Montoro J; Arcese W; Pérez-Simón JA; Schaap N; Maertens J; Vrhovac R; Lanza F; Gorin NC; Mohty M; Ciceri F Bone Marrow Transplant; 2023 Nov; 58(11):1197-1202. PubMed ID: 37553468 [TBL] [Abstract][Full Text] [Related]
2. Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Gorin NC; Labopin M; Czerw T; Pabst T; Blaise D; Dumas PY; Nemet D; Arcese W; Trisolini SM; Wu D; Huynh A; Zuckerman T; Meijer E; Cagirgan S; Cornelissen J; Houhou M; Polge E; Mohty M; Nagler A Cancer; 2017 Mar; 123(5):824-831. PubMed ID: 27906458 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Thiotepa-based Conditioning Regimens for Older Adults with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell Transplantation. Akhtar OS; Arshad S; Lian Q; Ahn KW; D'Souza A; Dhakal B; Mohan M; Pasquini M; Longo W; Shah NN; Fenske TS; Hamadani M Transplant Cell Ther; 2024 Dec; 30(12):1191.e1-1191.e8. PubMed ID: 39303985 [TBL] [Abstract][Full Text] [Related]
5. Uniform Graft-versus-Host Disease Prophylaxis using Post-Transplantation Cyclophosphamide, Methotrexate, and Cyclosporine following Peripheral Blood Hematopoietic Stem Cell Transplantation from Matched and Haploidentical Donors for Transfusion-Dependent Thalassemia: A Retrospective Report from the Bone Marrow Failure Working Group of Hunan Province, China. Gong S; Tian X; Yang R; Yang L; Wang Z; Yang K; Chen K; He X; Deng W; Yang X; Lei M; Fu B Transplant Cell Ther; 2024 Dec; 30(12):1213.e1-1213.e12. PubMed ID: 39236789 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of venetoclax combined with decitabine, modified HA regimen and DLI in the treatment of relapsed pediatric AML/MDS after allogeneic hematopoietic stem cell transplantation]. Zhang F; Wang HF; Hu GH; Suo P; Bai L; Wang Y; Zhang XH; Huang XJ; Cheng YF Zhonghua Xue Ye Xue Za Zhi; 2024 Sep; 45(9):832-837. PubMed ID: 39414606 [No Abstract] [Full Text] [Related]
7. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia]. Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596 [No Abstract] [Full Text] [Related]
8. Comparison between different reduced intensity conditioning regimens in AML/MDS patients in a Latin American center of adult stem cell transplantation. Salinas J; Flores Y; Rojas P; Gutierrez C; Vidal M; Jara V; Campbell J; García MJ; Sandoval V; Vergara M; Ocqueteau M; Palacios F; Sarmiento M Hematology; 2024 Dec; 29(1):2434274. PubMed ID: 39611732 [TBL] [Abstract][Full Text] [Related]
9. Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS. Radford M; Garcia-Horton A; Badami R; Jin E; Usmani N; Grafodatskaya D; McCready E; Khalaf D; Walker I; Leber B; Lepic K; Pond G; Berg T Transplant Cell Ther; 2024 Nov; ():. PubMed ID: 39547311 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
11. Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMT. Gorin NC; Labopin M; Blaise D; Dumas PY; Pabst T; Trisolini SM; Arcese W; Houhou M; Mohty M; Nagler A Am J Hematol; 2018 Jul; 93(7):859-866. PubMed ID: 29644709 [TBL] [Abstract][Full Text] [Related]
12. Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study. Jiang S; Lu X; Wei R; Zhang A; Chen H; Shi W; Xia L Ann Hematol; 2023 Nov; 102(11):3205-3216. PubMed ID: 37682324 [TBL] [Abstract][Full Text] [Related]
14. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
15. Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial. Short NJ; Nguyen D; Jabbour E; Senapati J; Zeng Z; Issa GC; Abbas H; Nasnas C; Qiao W; Huang X; Borthakur G; Chien K; Haddad FG; Pemmaraju N; Karrar OS; Nguyen D; Konopleva M; Kantarjian H; Ravandi F Lancet Haematol; 2024 Nov; 11(11):e839-e849. PubMed ID: 39303729 [TBL] [Abstract][Full Text] [Related]
16. Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation. Grunwald MR; Sha W; He J; Sanikommu S; Gerber JM; Ai J; Knight TG; Fasan O; Boseman V; Kaizen W; Chojecki A; Ragon BK; Symanowski J; Avalos B; Copelan E; Ghosh N Transplant Cell Ther; 2024 Dec; 30(12):1211.e1-1211.e11. PubMed ID: 39332808 [TBL] [Abstract][Full Text] [Related]
17. Modest survival benefits of autologous stem cell transplantation in multiple myeloma with renal impairment: a critical appraisal of the pre-antibody era. Li Y; Zhang X; Zou Z; Xiong Y; Gu X; Zou R; Tan J; Zhang L; Zheng Y; Niu T Clin Exp Med; 2024 Sep; 24(1):215. PubMed ID: 39249542 [TBL] [Abstract][Full Text] [Related]
18. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults. Kiene S; Albrecht M; Theurich S; Scheid C; Skoetz N; Holtick U Cochrane Database Syst Rev; 2024 Nov; 11(11):CD010189. PubMed ID: 39508306 [TBL] [Abstract][Full Text] [Related]
19. [CLAG±DAC regimen in the treatment of refractory/relapsed acute myeloid leukemia]. Hua WX; Yao WQ; Zhou M; Qi JQ; Kang HZ; Wang RJ; Cai CS; Liu YJ; Wu DP; Han Y Zhonghua Xue Ye Xue Za Zhi; 2024 Sep; 45(9):838-843. PubMed ID: 39414607 [No Abstract] [Full Text] [Related]
20. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early-stage Hodgkin's lymphoma. Goldkuhle M; Kreuzberger N; von Tresckow B; Eichenauer DA; Specht L; Monsef I; Skoetz N Cochrane Database Syst Rev; 2024 Dec; 12(12):CD007110. PubMed ID: 39620432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]